LIPOFEN Drug Patent Profile

✉ Email this page to a colleague

When do Lipofen patents expire, and what generic alternatives are available?

Lipofen is a drug marketed by Cipher Pharms Inc and is included in one NDA.

The generic ingredient in LIPOFEN is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lipofen

A generic version of LIPOFEN was approved as fenofibrate by RHODES PHARMS on May 13^th, 2005.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LIPOFEN?
What are the global sales for LIPOFEN?
What is Average Wholesale Price for LIPOFEN?

Summary for LIPOFEN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	138
Clinical Trials:	3
Patent Applications:	3,736
Drug Prices:	Drug price information for LIPOFEN
What excipients (inactive ingredients) are in LIPOFEN?	LIPOFEN excipients list
DailyMed Link:	LIPOFEN at DailyMed

Drug patent expirations by year for LIPOFEN

Recent Clinical Trials for LIPOFEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lindsay Ferguson, MD	Phase 1
National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Phase 2
The Scripps Research Institute	Phase 2

See all LIPOFEN clinical trials

Pharmacology for LIPOFEN

Drug Class	Peroxisome Proliferator Receptor alpha Agonist

US Patents and Regulatory Information for LIPOFEN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-001	Jan 11, 2006		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-002	Jan 11, 2006		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-003	Jan 11, 2006		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LIPOFEN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-001	Jan 11, 2006	⤷ Sign Up	⤷ Sign Up
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-003	Jan 11, 2006	⤷ Sign Up	⤷ Sign Up
Cipher Pharms Inc	LIPOFEN	fenofibrate	CAPSULE;ORAL	021612-002	Jan 11, 2006	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LIPOFEN

See the table below for patents covering LIPOFEN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	69627817		⤷ Sign Up
Japan	H10511959		⤷ Sign Up
Canada	2210985	COMPOSITION PHARMACEUTIQUE CONTENANT DU FENOFIBRATE ET DES GLYCERIDES POLYGLYCOLYSES (PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND POLYGLYCOLIZED GLYCERIDES)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LIPOFEN

Recent Clinical Trials for LIPOFEN

Pharmacology for LIPOFEN

Make Better Decisions: Try a trial or see plans & pricing